What are the diagnosis and treatment options for hyperandrogenism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Treatment of Hyperandrogenism

For diagnosing biochemical hyperandrogenism, free testosterone (FT) and total testosterone (TT) should be used as first-line laboratory tests, preferably measured using liquid chromatography with tandem mass spectrometry (LC-MS/MS) for highest accuracy. 1

Diagnostic Approach

Clinical Assessment

  • Evaluate for common clinical manifestations of hyperandrogenism including hirsutism (using modified Ferriman-Gallwey scoring), acne, androgenic alopecia, and in severe cases, virilization 2, 3
  • Assess for menstrual irregularities, as hyperandrogenism often presents with oligo/anovulation 4, 5
  • Record body mass index and blood pressure, as metabolic complications are common with hyperandrogenic conditions 4

Laboratory Testing

  • First-line testing should include:

    • Total testosterone (TT) and free testosterone (FT) measured by LC-MS/MS 1
    • Where mass spectrometry is unavailable, free androgen index (FAI) can be employed with good diagnostic accuracy 1
  • Second-line testing (if TT or FT not elevated):

    • Androstenedione (A4) and dehydroepiandrosterone sulfate (DHEAS), noting their poorer specificity 1
    • LH/FSH ratio (>2 suggests PCOS) 4
    • 17-hydroxyprogesterone to screen for non-classic congenital adrenal hyperplasia 5, 6
  • For severe or rapidly progressive hyperandrogenism with virilization:

    • Consider additional testing to rule out androgen-secreting tumors 3, 6
    • Overnight dexamethasone suppression test or 24-hour urinary free cortisol to exclude Cushing's disease 6

Differential Diagnosis

  • Polycystic ovary syndrome (PCOS) - most common cause of hyperandrogenism 4, 6
  • Non-classic congenital adrenal hyperplasia (NCCAH) 6
  • Cushing's disease 6
  • Androgen-secreting tumors (ovarian or adrenal) 3, 6
  • Idiopathic hyperandrogenism 5
  • Physiologic hyperandrogenism of puberty 5

Treatment Options

Pharmacological Approaches

  • First-line treatment: Combined oral contraceptives (COCs)

    • Effectively regulate menstrual cycles and reduce hyperandrogenism 4
    • Improve acne and hirsutism by suppressing androgen production 4, 2
  • Antiandrogen therapy:

    • Options include cyproterone acetate, spironolactone, and flutamide 3
    • Consider for patients with persistent symptoms despite COC therapy 2
    • 5α-reductase inhibitors may be used to block conversion of testosterone to dihydrotestosterone 2

Cosmetic Management for Hirsutism

  • Short-term options: shaving, chemical depilation, plucking, threading, waxing, and bleaching 2
  • Long-term options: electrolysis, laser therapy, and intense pulse light therapy 2
  • Topical eflornithine hydrochloride can be used as adjunctive therapy 2

Metabolic Management

  • Screen for and manage metabolic complications, particularly insulin resistance 4
  • Consider lifestyle modifications including diet and exercise for overweight/obese patients 4

Treatment Response Timeline

  • Acne typically responds relatively quickly to therapy 2
  • Hirsutism improvement may be observed as early as 3 months, but typically requires 6-8 months of consistent therapy 2
  • Female pattern hair loss (FPHL) is slowest to respond, potentially requiring 12-18 months of therapy, and may not improve in all cases 2

Important Clinical Considerations

  • Virilization (clitoromegaly, deepening voice, increased muscle mass) is uncommon in typical hyperandrogenism and warrants investigation for androgen-secreting tumors 3, 6
  • The psychological impact of hyperandrogenism symptoms should be addressed as part of comprehensive care 4
  • Treatment should not be withheld during ongoing evaluation for underlying causes 5
  • Patient expectations regarding treatment timeline and efficacy should be discussed before initiating therapy 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Androgen excess: Investigations and management.

Best practice & research. Clinical obstetrics & gynaecology, 2016

Research

[Hyperandrogenism, adrenal dysfunction, and hirsutism].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2020

Guideline

Diagnosis and Treatment of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.